Literature DB >> 9577416

Pulmonary and cardiac function in advanced fibrodysplasia ossificans progressiva.

W G Kussmaul1, A N Esmail, Y Sagar, J Ross, S Gregory, F S Kaplan.   

Abstract

Fibrodysplasia ossificans progressiva is a rare genetic disease characterized by heterotopic ossification in soft tissues. Severe disability results from progressive immobilization of the limbs, jaw, and chest wall. To determine whether cardiac function is altered in this disease, 25 patients ranging in age from 5 to 55 years (disease duration 1-51 years) were studied. History, physical examination, pulmonary functions, electrocardiography, and echocardiography were performed on each patient. Physical examination of the lungs and heart was unrevealing; no right sided ventricular gallops were heard, and no patient was found to have neck vein distention or peripheral edema. The patients had extremely limited chest expansion (1.9 +/- 0.8 inches), suggesting dependence on diaphragmatic breathing. Lung volumes were severely reduced (mean forced vital capacity 44% +/- 14% of predicted), but flow rates were relatively normal. All patients had normal capillary oxygen saturation. Echocardiography was technically difficult, but no abnormalities of left or right ventricular function were seen. Ten (40%) patients had electrocardiographic evidence of right ventricular dysfunction. Compared with patients without such evidence, these patients were older, had significantly longer disease duration, higher hemoglobin, and more impaired pulmonary function. The results of this study suggest that the presence of severely restrictive chest wall disease is associated with a high incidence of right ventricular abnormalities on electrocardiogram. Whether cor pulmonale will eventually occur remains to be determined.

Entities:  

Mesh:

Year:  1998        PMID: 9577416

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  20 in total

1.  Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31.

Authors:  G Feldman; M Li; S Martin; M Urbanek; J A Urtizberea; M Fardeau; M LeMerrer; J M Connor; J Triffitt; R Smith; M Muenke; F S Kaplan; E M Shore
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Fibrodysplasia ossificans progressiva without characteristic skeletal anomalies.

Authors:  Hasan Ulusoy
Journal:  Rheumatol Int       Date:  2010-03-27       Impact factor: 2.631

3.  Fibrodysplasia ossificans progressiva - radiological findings: a case report.

Authors:  Ishaq Al-Salmi; Sameer Raniga; Aymen Al Hadidi
Journal:  Oman Med J       Date:  2014-09

Review 4.  Molecular and cellular mechanisms of heterotopic ossification.

Authors:  Diana M Ramirez; Melissa R Ramirez; Anthony M Reginato; Damian Medici
Journal:  Histol Histopathol       Date:  2014-05-05       Impact factor: 2.303

Review 5.  Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.

Authors:  Robert J Pignolo; Eileen M Shore; Frederick S Kaplan
Journal:  Pediatr Endocrinol Rev       Date:  2013-06

6.  Pregnancy in fibrodysplasia ossificans progressiva.

Authors:  Javaid A Muglu; Aditya Garg; T Pandiarajan; Eileen M Shore; Frederick S Kaplan; Dhiraj Uchil; Malcolm J Dickson
Journal:  Obstet Med       Date:  2011-12-08

7.  General anesthesia in fibrodysplasia ossificans progressive: a case report and clinical review.

Authors:  Jin-Xing Liu; Rong Hu; Yu Sun; Hong Jiang
Journal:  Int J Clin Exp Med       Date:  2014-05-15

8.  When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP).

Authors:  Frederick S Kaplan; Jay Groppe; Eileen M Shore
Journal:  Drug Discov Today Ther Strateg       Date:  2008

Review 9.  The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling.

Authors:  Frederick S Kaplan; Robert J Pignolo; Eileen M Shore
Journal:  Cytokine Growth Factor Rev       Date:  2009-11-06       Impact factor: 7.638

Review 10.  Granting immunity to FOP and catching heterotopic ossification in the Act.

Authors:  Frederick S Kaplan; Robert J Pignolo; Eileen M Shore
Journal:  Semin Cell Dev Biol       Date:  2015-12-17       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.